Sherman, MA, Graf, R, Sabbagh, SE, Galindo-Feria, AS, Pinal-Fernandez, I, Pak, K, Kishi, T, Flegel, WA, Targoff, IN, Miller, FW, Lundberg, IE, Rider, LG, Mammen, AL, Albert, DA, Arabshahi, B, Balboni, IM, Ballinger, S, Barillas-Arias, L, Becker, ML, Bingham, CA, Bohnsack, JF, Carrasco, R, Cartwright, VW, Cron, RQ, Curiel, R, Dare, JA
, De La Pena, W, Deguzman, MM, Eberhard, BA, Edelheit, BS, Finkel, TH, George, SW, Gewanter, HL, Goldmuntz, EA, Groh, BP, Haftel, HH, Hannan, WP, Henrickson, M, Higgins, GC, Hobday, PM, Hopp, RJ, Huber, AM, Imundo, L, Inman, CJ, Jansen, A, Jarvis, J, Jones, OY, Kamdar, A, Kim, H, Kingsbury, DJ, Lindsley, CB, Mamyrova, G, McCarthy, PL, Mitchell, SR, Murphy, FT, Nanda, K, O'Hanlon, T, Oral, EA, Pachman, LM, Perez, MD, Person, DA, Rabinovich, CE, Ronis, T, Schiffenbauer, A, Shaham, B, Sinal, SH, Soep, J, Stoll, ML, Sule, S, Tarvin, S, Vogelgesang, SA, Volochayev, R, Wargula, JC & White, PH 2023, '
Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features',
Rheumatology (United Kingdom), vol. 62, no. SI2, pp. SI226-SI234.
https://doi.org/10.1093/rheumatology/keac428